Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000919574-26-007454·NovaBridge Biosciences
Schedule 13D ownership disclosure
NOVABRIDGE BIOSCIENCES
Ordinary Shares, par value $0.0001 per share · CUSIP: 44975P103
Event date: 2026-11-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- HHLR Advisors, Ltd.Reported CIK 0001762304
Shares: 13,295,306.00 · Class: 4.9%
- Hillhouse Investment Management, Ltd.Reported CIK 0001510589
Shares: 13,295,306.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-007454
- Form type
- SCHEDULE 13D/A
- Filer
- NovaBridge Biosciences
- CIK
- CIK 1778016
- Filed
- Nov 05, 2026
- Reporting period
- Nov 05, 2026
- Description
- Schedule 13D beneficial ownership